Serodiagnosis of Anti-glomerular Basement Membrane Disease Using a Newly Developed Chemiluminescence Immunoassay
Open Access
- 4 July 2022
- journal article
- research article
- Published by Frontiers Media SA in Frontiers in Medicine
- Vol. 9, 915754
Abstract
Circulating autoantibodies directed against the kidney glomerular basement membrane (GBM) antigens are important markers in the diagnosis and monitoring of autoimmune glomerulonephritides, including the classic Goodpasture's syndrome. Rapid and reliable diagnostic tools for the detection of anti-GBM autoantibodies are crucial as anti-GBM disease can progress rapidly and, if too late or incorrectly diagnosed, can have serious, even fatal consequences. The performance of the newly developed standardized chemiluminescence immunoassay (ChLIA) was evaluated in comparison with the established Anti-GBM ELISA (IgG) (EUROIMMUN). For the assessment of its diagnostic performance, sera from 67 clinically characterized anti-GBM disease patients and 221 disease controls were analyzed. The clinical sensitivity of the Anti-GBM ChLIA (IgG) reached 100% at a specificity of 98.6%. The Anti-GBM ELISA (IgG) performance was less sensitive (89.6%) without any positive findings in the control group, indicating a specificity of 100%. Both methods were homogeneous (κ = 0.901). The Anti-GBM ChLIA (IgG) represents a promising alternative tool for accurate anti-GBM assessment in routine diagnostic settings with the advantage of rapid turnaround time and fully automated random-access processing.Keywords
This publication has 18 references indexed in Scilit:
- RETRACTED: Autoantibodies in Renal Diseases – Clinical Significance and Recent Developments in Serological DetectionFrontiers in Immunology, 2015
- Goodpasture's syndrome: A clinical updateAutoimmunity Reviews, 2015
- Diagnosis and classification of Goodpasture's disease (anti-GBM)Journal of Autoimmunity, 2014
- Circulating anti‐glomerular basement membrane autoantibodies against α3(IV)NC1 undetectable by commercially available enzyme‐linked immunosorbent assaysNephrology, 2011
- Levels of epitope-specific autoantibodies correlate with renal damage in anti-GBM diseaseNephrology Dialysis Transplantation, 2009
- Natural anti-GBM antibodies from normal human sera recognize α3(IV)NC1 restrictively and recognize the same epitopes as anti-GBM antibodies from patients with anti-GBM diseaseClinical Immunology, 2007
- The Prognostic Significance in Goodpasture’s Disease of Specificity, Titre and Affinity of Anti-Glomerular-Basement-Membrane AntibodiesNephron Clinical Practice, 2003
- Anti-neutrophil cytoplasm antibodies and anti-glomerular basement membrane antibodies: Two coexisting distinct autoreactivities detectable in patients with rapidly progressive glomerulonephritisAmerican Journal of Kidney Diseases, 1995
- Molecular cloning of the human Goodpasture antigen demonstrates it to be the alpha 3 chain of type IV collagen.Journal of Clinical Investigation, 1992
- Identification of the Goodpasture antigen as the alpha 3(IV) chain of collagen IV.Journal of Biological Chemistry, 1988